INTERNATIONAL PATENT: THERAKIND LIMITED FILES APPLICATION FOR "ANTIMICROBIAL USE OF ANNEXIN A1 PROTEIN"

GENEVA, April 28 -- THERAKIND LIMITED (3rd Floor, Regents Park RoadLondon N3 2JX) filed a patent application (PCT/GB2024/052643) for "ANTIMICROBIAL USE OF ANNEXIN A1 PROTEIN" on Oct 15, 2024. With publication no. WO/2025/083394, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRAMIGNOLI, Roberto (Avd. PatalogiANA Futura- Karolinska InstitutetAlfred Nobels alle 8, plan 814152 Huddinge), IOVINO, Federico (Biomedicum7D quarter, Solnavagen 9Karolinska Institutet17165 Solna)

Abstract: There is described Annexin A1 protein, ...